Looking for help?

Find answers to your questions

GHB

What is GHB?

Gamma hydroxybutyrate (GHB) is a central nervous system depressant that is commonly used as a recreational drug. It is also used for medical purposes as a treatment for narcolepsy and alcohol withdrawal syndrome. GHB is a colorless, odorless liquid that is often sold as a powder or a clear liquid. GBL (gamma butyrolactone) and 1,4-BD (1,4-butanediol) are chemicals that are closely related to GHB. Once GBL or 1,4-BD enter the body, they convert to GHB almost immediately.

History

GHB was first synthesized in the 1960s as an experimental anesthetic. It was later found to have sedative effects and was used as a treatment for insomnia and anxiety. In the 1980s, GHB became popular as a bodybuilding supplement, and in the 1990s, it gained popularity as a recreational drug. In 2002, GHB was classified as a Schedule I controlled substance in the United States due to its high potential for abuse and dependence.

Chemistry

GHB is a naturally occurring substance that is found in the human body. It is a derivative of the neurotransmitter gamma-aminobutyric acid (GABA) and is structurally similar to GABA. GHB is classified as a type of hydroxy acid and is soluble in water and alcohol.

Pharmacology

GHB acts on the GABA receptors in the brain, which are responsible for controlling the activity of neurons. When GHB binds to these receptors, it inhibits the activity of the neurons, leading to a sedative effect. GHB also increases the release of dopamine in the brain, which can lead to feelings of euphoria and relaxation.

Positive Effects

When used therapeutically, GHB can have positive effects such as reducing anxiety, improving sleep quality, and reducing symptoms of alcohol withdrawal syndrome. In recreational use, GHB can cause feelings of relaxation, euphoria, and increased sociability.

Negative Effects

GHB can have negative effects such as dizziness, nausea, vomiting, and confusion. In higher doses, GHB can cause unconsciousness, respiratory depression, and even coma. GHB can also lead to memory loss and amnesia, which can be dangerous if the user engages in risky behavior while under the influence.

Recreational Use

GHB is commonly used as a recreational drug due to its sedative and euphoric effects. It is often used in social settings such as clubs or parties. However, recreational use of GHB can be dangerous due to its potential for overdose and addiction.

Medicinal Use

GHB is used medically as a treatment for narcolepsy and alcohol withdrawal syndrome. It is also being studied as a potential treatment for fibromyalgia and chronic fatigue syndrome.

Combinations

GHB should not be used in combination with other depressants such as alcohol or benzodiazepines, as this can lead to dangerous levels of sedation and respiratory depression. GHB can also interact with certain medications, such as anticonvulsants and antidepressants.

Addiction and Harm Potential

GHB has a high potential for addiction and dependence. Withdrawal symptoms can include anxiety, insomnia, and tremors. Long-term use of GHB can lead to memory loss, cognitive impairment, and damage to the liver and kidneys.

Warnings

GHB is a dangerous drug when used improperly. It is important to use caution when using GHB and to avoid using it in combination with other drugs or alcohol. GHB should only be used under the guidance of a medical professional for therapeutic purposes.

Conclusion

GHB is a central nervous system depressant that is commonly used as a recreational drug. It is also used for medical purposes as a treatment for narcolepsy and alcohol withdrawal syndrome. GHB has both positive and negative effects, and its recreational use can be dangerous due to its potential for overdose and addiction. It is important to use caution when using GHB and to avoid using it recreationally or in combination with other drugs or alcohol. GHB should only be used under the guidance of a medical professional for therapeutic purposes.

References

  • National Institute on Drug Abuse. (2018). GHB and its analogs: What are they?
  • Drug Enforcement Administration. (2019). Drug scheduling. Retrieved from https://www.dea.gov/drug-scheduling
  • European Monitoring Centre for Drugs and Drug Addiction. (2018). GHB and its precursor GBL: An emerging trend case study.

 

Updated on 25 Apr 2023